Cardiovascular Consequences of Obesity and Targets for Treatment

Area of Science:

• Cardiology
• Metabolic Disorders
• Pharmacology

Background:

• Obesity is a significant risk factor for cardiovascular disease (CVD), encompassing conditions like coronary artery disease and heart failure.
• The precise biological mechanisms linking obesity to CVD pathogenesis are not fully elucidated.
• Existing therapeutic strategies primarily involve lifestyle modifications and managing comorbid conditions.

Purpose of the Study:

• To review the current understanding of obesity's impact on cardiovascular health.
• To discuss established and emerging therapeutic approaches for obesity-related CVD.
• To explore potential novel drug development pathways targeting obesity-associated cardiovascular dysfunction.

Main Methods:

• Literature review of obesity and cardiovascular disease mechanisms.
• Analysis of current treatment guidelines for obesity and CVD.
• Exploration of preclinical and clinical research on novel therapeutic targets.

Main Results:

• Obesity contributes to CVD through various pathways including inflammation, oxidative stress, and hormonal dysregulation.
• Weight reduction and management of hypertension, dyslipidemia, and diabetes are key therapeutic goals.
• Several molecular targets and pathways are under investigation for future pharmacological interventions.

Conclusions:

• Understanding the intricate mechanisms of obesity-induced CVD is crucial for effective prevention and treatment.
• A multi-faceted approach combining lifestyle changes, risk factor control, and targeted pharmacotherapy holds promise.
• Further research into novel drug targets may lead to more effective treatments for obesity-related cardiovascular complications.